메뉴 건너뛰기




Volumn 78, Issue 6, 2014, Pages 1298-1314

The central nervous system effects of the partial GABA-Aα2,3-selective receptor modulator AZD7325 in comparison with lorazepam in healthy males

Author keywords

Agonism; AZD7325; GABAergic; Pharmacodynamic; Selective

Indexed keywords

4 AMINO 8 (2 FLUORO 6 METHOXYPHENYL) N PROPYLCINNOLINE 3 CARBOXAMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; FLUMAZENIL; FLUMAZENIL C 11; LORAZEPAM; PLACEBO; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; 4-AMINO-8-(2-FLUORO-6-METHOXY-PHENYL)-N-PROPYLCINNOLINE-3-CARBOXAMIDE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; FUSED HETEROCYCLIC RINGS; GABRA2 PROTEIN, HUMAN;

EID: 84919330849     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12413     Document Type: Article
Times cited : (37)

References (40)
  • 1
    • 77953144335 scopus 로고    scopus 로고
    • Subtype-selective GABAA receptor modulation yields a novel pharmacological profile: The design and development of TPA023
    • Atack JR. Subtype-selective GABAA receptor modulation yields a novel pharmacological profile: the design and development of TPA023. Adv Pharmacol 2009; 57: 137-85.
    • (2009) Adv Pharmacol , vol.57 , pp. 137-185
    • Atack, J.R.1
  • 3
    • 14144254686 scopus 로고    scopus 로고
    • Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates
    • Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A 2005; 102: 915-20.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 915-920
    • Rowlett, J.K.1    Platt, D.M.2    Lelas, S.3    Atack, J.R.4    Dawson, G.R.5
  • 5
    • 58749098563 scopus 로고    scopus 로고
    • Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice
    • Knabl J, Zeilhofer UB, Crestani F, Rudolph U, Zeilhofer HU. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice. Pain 2009; 141: 233-8.
    • (2009) Pain , vol.141 , pp. 233-238
    • Knabl, J.1    Zeilhofer, U.B.2    Crestani, F.3    Rudolph, U.4    Zeilhofer, H.U.5
  • 6
    • 33750608691 scopus 로고    scopus 로고
    • L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for ?5-containing GABAA receptors
    • Atack JR, Bayley PJ, Seabrook GR, Wafford KA, McKernan RM, Dawson GR. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for ?5-containing GABAA receptors. Neuropharmacology 2006; 51: 1023-9.
    • (2006) Neuropharmacology , vol.51 , pp. 1023-1029
    • Atack, J.R.1    Bayley, P.J.2    Seabrook, G.R.3    Wafford, K.A.4    McKernan, R.M.5    Dawson, G.R.6
  • 8
    • 84862135304 scopus 로고    scopus 로고
    • A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator-an in vitro and in vivo comparison
    • Zhou D, Sunzel M, Ribadeneira MD, Smith MA, Desai D, Lin J, Grimm SW. A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator-an in vitro and in vivo comparison. Br J Clin Pharmacol 2012; 74: 98-108.
    • (2012) Br J Clin Pharmacol , vol.74 , pp. 98-108
    • Zhou, D.1    Sunzel, M.2    Ribadeneira, M.D.3    Smith, M.A.4    Desai, D.5    Lin, J.6    Grimm, S.W.7
  • 10
    • 77749286348 scopus 로고    scopus 로고
    • A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder
    • Czobor P, Skolnick P, Beer B, Lippa A. A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder. CNS Neurosci Ther 2010; 16: 63-75.
    • (2010) CNS Neurosci Ther , vol.16 , pp. 63-75
    • Czobor, P.1    Skolnick, P.2    Beer, B.3    Lippa, A.4
  • 11
    • 0026651852 scopus 로고
    • Alpidem and lorazepam in the treatment of patients with anxiety disorders: Comparison of physiological and psychological effects
    • Morton S, Lader M. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects. Pharmacopsychiatry 1992; 25: 177-81.
    • (1992) Pharmacopsychiatry , vol.25 , pp. 177-181
    • Morton, S.1    Lader, M.2
  • 13
    • 84867861360 scopus 로고    scopus 로고
    • Anxioselective anxiolytics: On a quest for the Holy Grail
    • Skolnick P. Anxioselective anxiolytics: on a quest for the Holy Grail. Trends Pharmacol Sci 2012; 33: 611-20.
    • (2012) Trends Pharmacol Sci , vol.33 , pp. 611-620
    • Skolnick, P.1
  • 16
    • 67651162145 scopus 로고    scopus 로고
    • The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABAA 2,3 selective receptor modulator, in comparison with lorazepam in healthy volunteers
    • de Haas SL, Franson KL, Schmitt JA, Cohen AF, Fau JB, Dubruc C, van Gerven JM. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABAA 2,3 selective receptor modulator, in comparison with lorazepam in healthy volunteers. J Psychopharmacol 2009; 23: 625-32.
    • (2009) J Psychopharmacol , vol.23 , pp. 625-632
    • De Haas, S.L.1    Franson, K.L.2    Schmitt, J.A.3    Cohen, A.F.4    Fau, J.B.5    Dubruc, C.6    Van Gerven, J.M.7
  • 18
    • 24944537064 scopus 로고    scopus 로고
    • A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial receptor modulator
    • Lingford-Hughes A, Wilson SJ, Feeney A, Grasby PG, Nutt DJ. A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial receptor modulator. Psychopharmacology (Berl) 2005; 180: 789-91.
    • (2005) Psychopharmacology (Berl , vol.180 , pp. 789-791
    • Lingford-Hughes, A.1    Wilson, S.J.2    Feeney, A.3    Grasby, P.G.4    Nutt, D.J.5
  • 20
    • 0015032067 scopus 로고
    • The action of sedatives on brain stem oculomotor systems in man
    • Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 1971; 10: 181-91.
    • (1971) Neuropharmacology , vol.10 , pp. 181-191
    • Norris, H.1
  • 23
    • 84987469571 scopus 로고
    • The use of analogue scales in rating subjective feelings
    • Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974; 47: 211-8.
    • (1974) Br J Med Psychol , vol.47 , pp. 211-218
    • Bond, A.1    Lader, M.2
  • 28
    • 0025861138 scopus 로고
    • A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers
    • van Steveninck AL, Schoemaker HC, Pieters MS, Kroon R, Breimer DD, Cohen AF. A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers. Clin Pharmacol Ther 1991; 50: 172-80.
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 172-180
    • Van Steveninck, A.L.1    Schoemaker, H.C.2    Pieters, M.S.3    Kroon, R.4    Breimer, D.D.5    Cohen, A.F.6
  • 29
    • 0019481389 scopus 로고
    • The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration
    • Bittencourt PR, Wade P, Smith AT, Richens A. The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. Br J Clin Pharmacol 1981; 12: 523-33.
    • (1981) Br J Clin Pharmacol , vol.12 , pp. 523-533
    • Bittencourt, P.R.1    Wade, P.2    Smith, A.T.3    Richens, A.4
  • 30
    • 0016757691 scopus 로고
    • Quantitative measurement of saccade amplitude, duration, and velocity
    • Baloh RW, Sills AW, Kumley WE, Honrubia V. Quantitative measurement of saccade amplitude, duration, and velocity. Neurology 1975; 25: 1065-70.
    • (1975) Neurology , vol.25 , pp. 1065-1070
    • Baloh, R.W.1    Sills, A.W.2    Kumley, W.E.3    Honrubia, V.4
  • 31
    • 78650080774 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects
    • de Haas SL, Schoemaker RC, van Gerven JM, Hoever P, Cohen AF, Dingemanse J. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects. J Psychopharmacol 2010; 24: 1619-29.
    • (2010) J Psychopharmacol , vol.24 , pp. 1619-1629
    • De Haas, S.L.1    Schoemaker, R.C.2    Van Gerven, J.M.3    Hoever, P.4    Cohen, A.F.5    Dingemanse, J.6
  • 32
    • 0021747027 scopus 로고
    • Visual motor co-ordination and dynamic visual acuity
    • Borland RG, Nicholson AN. Visual motor co-ordination and dynamic visual acuity. Br J Clin Pharmacol 1984; 18: (Suppl. 1): 69S-72S.
    • (1984) Br J Clin Pharmacol , vol.18 , pp. 69S-72S
    • Borland, R.G.1    Nicholson, A.N.2
  • 33
    • 0022409205 scopus 로고
    • Lamotrigine (BW430C), a potential anticonvulsant: Effects on the central nervous system in comparison with phenytoin and diazepam
    • Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C), a potential anticonvulsant: effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985; 20: 619-29.
    • (1985) Br J Clin Pharmacol , vol.20 , pp. 619-629
    • Cohen, A.F.1    Ashby, L.2    Crowley, D.3    Land, G.4    Peck, A.W.5    Miller, A.A.6
  • 34
    • 34248517196 scopus 로고    scopus 로고
    • Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase i study
    • Collie A, Darekar A, Weissgerber G, Toh MK, Snyder PJ, Maruff P, Huggins JP. Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study. Contemp Clin Trials 2007; 28: 391-400.
    • (2007) Contemp Clin Trials , vol.28 , pp. 391-400
    • Collie, A.1    Darekar, A.2    Weissgerber, G.3    Toh, M.K.4    Snyder, P.J.5    Maruff, P.6    Huggins, J.P.7
  • 35
    • 21044455735 scopus 로고    scopus 로고
    • A method for determining the magnitude of change across different cognitive functions in clinical trials: The effects of acute administration of two different doses of alprazolam
    • Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses of alprazolam. Hum Psychopharmacol 2005; 20: 263-73.
    • (2005) Hum Psychopharmacol , vol.20 , pp. 263-273
    • Snyder, P.J.1    Werth, J.2    Giordani, B.3    Caveney, A.F.4    Feltner, D.5    Maruff, P.6
  • 36
    • 84866599278 scopus 로고    scopus 로고
    • Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer's disease measured using the International Shopping List Test
    • Lim YY, Harrington K, Ames D, Ellis KA, Lachovitzki R, Snyder PJ, Maruff P. Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer's disease measured using the International Shopping List Test. J Clin Exp Neuropsychol 2012; 34: 853-63.
    • (2012) J Clin Exp Neuropsychol , vol.34 , pp. 853-863
    • Lim, Y.Y.1    Harrington, K.2    Ames, D.3    Ellis, K.A.4    Lachovitzki, R.5    Snyder, P.J.6    Maruff, P.7
  • 37
    • 84863387280 scopus 로고    scopus 로고
    • An overview of the CNS-pharmacodynamic profiles of non-selective and selective GABA receptor modulators
    • Chen X, de Haas S, de Kam M, van Gerven J. An overview of the CNS-pharmacodynamic profiles of non-selective and selective GABA receptor modulators. Adv Pharmacol Sci 2012; 2012: 134523. doi: 10.1155/2012/134523.
    • (2012) Adv Pharmacol Sci , vol.2012 , pp. 134523
    • Chen, X.1    De Haas, S.2    De Kam, M.3    Van Gerven, J.4
  • 39
    • 84919350298 scopus 로고    scopus 로고
    • Available at last accessed 5 January 2014
    • AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD). Available at http://clinicaltrials .gov/show/NCT00808249 (last accessed 5 January 2014).
  • 40
    • 84919350297 scopus 로고    scopus 로고
    • Available at last accessed 5 January 2014
    • Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325. Available at http://clinicaltrials .gov/ct2/show/NCT00807937?term=AZD7325&rank=10 (last accessed 5 January 2014).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.